Michael Kelly News
-
Johnson & Johnson’s DePuy unit defectively designed a metal-on-metal hip implant and was negligent, a California jury decided in the first of 10,750 lawsuits over the device to go to trial.
-
Johnson & Johnson’s pursuit of profit led it to sell a defective metal-on-metal hip that failed faster than any similar device, a lawyer argued at the first of 10,750 lawsuits over the recalled implant to go to trial.
-
A witness for Johnson & Johnson miscalculated in testifying that a Montana man’s metal hip device failed because of the angle at which it was implanted, the man’s lawyer said in cross-examination.
-
A witness for Johnson & Johnson testified that an infection led a Montana man to have his metal- on-metal hip device replaced, not a defect in the prosthesis.
-
China Petrochemical Corp.’s $1.02 billion deal with Chesapeake Energy Corp. gives the second- largest Chinese energy producer a stake in a shale oilfield for less than one-third of its estimated value.
-
China Petrochemical Corp.’s $1.02 billion deal with Chesapeake Energy Corp. gives the second- largest Chinese energy producer a stake in a shale oilfield for less than one-third of its estimated value.
-
Fox Rothschild LLP poached a team of eight attorneys from Day Pitney LLP to open a Morristown, New Jersey, office this summer that specializes in real estate.
-
A California surgeon who designed Johnson & Johnson’s recalled metal hips testified that he gave complaints about the devices to the marketing department and never knew of the group designated to probe such matters.
-
The lead surgeon-designer for Johnson & Johnson’s recalled metal-on-metal hip implants testified that he wouldn’t have sold the device if he knew it would have a failure rate of 20 percent or more.
-
A bioengineer at Johnson & Johnson’s DePuy unit testified that he spent three years studying a redesign of metal-on-metal hip devices that the company recalled in 2010 because of their failure rate.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page